Human Reproduction, Vol. 15, No. 2, 319-324,
February 2000
© 2000 European Society of Human Reproduction and Embryology
Experience with the elective transfer of two embryos under the conditions of the German embryo protection law: results of a retrospective data analysis of 2573 transfer cycles
1 Department of Gynecology and Obstetrics and 2 Department of Social Medicine, Medical University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany
The German embryo protection law (Embryonenschutzgesetz, ESchG) does not allow embryo selection. Therefore, only as many oocytes at the pronuclear stage (PN), as are planned to be transferred, are allowed to be cultured. It is not known whether, under these conditions, it is possible to reduce the number of embryos for transfer without a corresponding reduction of the overall pregnancy rate (PR). We retrospectively analysed 2573 consecutive transfer cycles following either in-vitro fertilization (IVF) or IVF/intracytoplasmic sperm injection. Out of these cycles, 234, 329 and 792 were performed with one, two, and three embryos respectively, because only that number was available (non-elective transfer). Another 123 and 1095 transfer cycles were performed with two and three embryos, respectively, which were selected from a higher number of PN oocytes (elective transfer). The clinical ongoing PR were 3.9, 9.1 and 17.7% respectively for the groups with non-elective transfer of 1, 2 and 3 embryos, and 22.0 and 22.5% for the groups with elective transfers with two and three embryos, respectively. There was no statistically significant difference in PR between the two elective embryo transfer groups up to the age of 40 years. The multiple pregnancy rate was reduced by 7.9%. The reduction of the number of embryos transferred from three to two can be performed even under the conditions of the ESchG without an effect on the overall PR.
Key words: elective embryo transfer/German embryo protection law/multiple pregnancy rates/pronuclear stage selection
3 To whom correspondence should be addressed
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Manheimer, G. Zhang, L. Udoff, A. Haramati, P. Langenberg, B. M Berman, and L. M Bouter Effects of acupuncture on rates of pregnancy and live birth among women undergoing in vitro fertilisation: systematic review and meta-analysis BMJ, March 8, 2008; 336(7643): 545 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P.A. van Montfoort, J. P.M. Geraedts, J. C.M. Dumoulin, A. P.M. Stassen, J. L.H. Evers, and T. A.Y. Ayoubi Differential gene expression in cumulus cells as a prognostic indicator of embryo viability: a microarray analysis Mol. Hum. Reprod., March 1, 2008; 14(3): 157 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Griesinger, M. Weig, A. Schroer, K. Diedrich, and E.M. Kolibianakis Mid-cycle serum levels of endogenous LH are not associated with the likelihood of pregnancy in artificial frozen-thawed embryo transfer cycles without pituitary suppression Hum. Reprod., October 1, 2007; 22(10): 2589 - 2593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Griesinger, S. von Otte, A. Schroer, A.K. Ludwig, K. Diedrich, S. Al-Hasani, and A. Schultze-Mosgau Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study Hum. Reprod., May 1, 2007; 22(5): 1348 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Legge, R. Fitzgerald, and N. Frank A retrospective study of New Zealand case law involving assisted reproduction technology and the social recognition of 'new' family Hum. Reprod., January 1, 2007; 22(1): 17 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. James, S. Hennessy, B. Reggio, K. Wiemer, F. Larsen, and J. Cohen The limited importance of pronuclear scoring of human zygotes Hum. Reprod., June 1, 2006; 21(6): 1599 - 1604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.M. Kolibianakis, A. Schultze-Mosgau, A. Schroer, A. van Steirteghem, P. Devroey, K. Diedrich, and G. Griesinger A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists Hum. Reprod., October 1, 2005; 20(10): 2887 - 2892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Griesinger, A. Schultze-Mosgau, K. Dafopoulos, A. Schroeder, A. Schroer, S. von Otte, D. Hornung, K. Diedrich, and R. Felberbaum Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol Hum. Reprod., May 1, 2005; 20(5): 1200 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M.R. Gerris Single embryo transfer and IVF/ICSI outcome: a balanced appraisal Hum. Reprod. Update, March 1, 2005; 11(2): 105 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Unger, M. Hoopmann, R. Bald, D. Foth, and F. Nawroth Monozygotic triplets and monozygotic twins after ICSI and transfer of two blastocysts: case report Hum. Reprod., January 1, 2004; 19(1): 110 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ludwig, A. Katalinic, C. Banz, A.K. Schroder, M. Loning, J.M. Weiss, and K. Diedrich Tailoring the GnRH antagonist cetrorelix acetate to individual patients' needs in ovarian stimulation for IVF: results of a prospective, randomized study Hum. Reprod., November 1, 2002; 17(11): 2842 - 2845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Ozturk, S. Bhattacharya, and A. Templeton Avoiding multiple pregnancies in ART: Evaluation and implementation of new strategies Hum. Reprod., July 1, 2001; 16(7): 1319 - 1321. [Abstract] [Full Text] [PDF]
|
|